Patent reforms could address a problem that’s been driving rising prescription drug costs and create a more competitive ...
Raphael Pharmaceutical Inc. ('Raphael Pharmaceutical” or the 'Company”) (OTCQB: RAPH), a clinical-stage biotechnology company ...
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...
As companies and markets increasingly view patents not just as a defensive shield but as strategic assets (e.g., for licensing, enforcement, or ...
The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
Newly filed patent details a real-time, multi-modal content authentication system; positions Digitalage for B2B licensing to social media platforms, newsrooms, and AI providers TEMECULA, CA / ACCESS N ...
A federal jury in California ruled that Apple must compensate Masimo $634 million for infringing its patented blood-oxygen ...
Opinion: Medtronic's legal team increased the value delivered by their IP portfolio using a four-part strategy: Strategic ...
The patent world is at a moment of change. The incentives for obtaining and aggressively monetizing patents are increasing.
The U.S. Court of Appeals for the Federal Circuit on Friday affirmed a district court’s award of attorney’s fees to an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback